Koa Shoji Holdings Co.,Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Dividend History 4Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥18 | +12.5% |
| 2025 | ¥16 | +23.1% |
| 2024 | ¥13 | +8.3% |
| 2023 | ¥12 | +9.1% |
| 2022 | ¥11 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥20,353M | ¥22,053M | ¥22,134M | ¥24,679M |
| Gross Profit | ¥5,934M | ¥6,443M | ¥6,640M | ¥8,004M |
| Operating Income | ¥3,807M | ¥4,250M | ¥4,382M | ¥5,476M |
| Pretax Income | ¥3,765M | ¥4,099M | ¥4,376M | ¥5,548M |
| Net Income | ¥2,359M | ¥2,687M | ¥2,946M | ¥3,749M |
| EPS | ¥59.55 | ¥67.83 | ¥74.14 | - |
| Operating Margin | 18.71% | 19.27% | 19.80% | 22.19% |
| Balance Sheet | ||||
| Total Assets | ¥26,250M | ¥28,464M | ¥32,004M | ¥39,533M |
| Total Equity | ¥18,666M | ¥20,923M | ¥25,052M | ¥31,180M |
| Total Liabilities | ¥7,584M | ¥7,541M | ¥6,952M | ¥8,352M |
| Cash | ¥9,123M | ¥10,767M | ¥13,955M | ¥17,210M |
| Interest-bearing Debt | ¥3,491M | ¥3,141M | ¥2,825M | ¥3,322M |
| Equity Ratio | 71.11% | 73.51% | 78.28% | 78.87% |
| D/E Ratio | 0.19 | 0.15 | 0.11 | 0.11 |
| Cash Flow | ||||
| Operating CF | ¥2,094M | ¥2,737M | ¥3,831M | ¥7,592M |
| Investing CF | -¥477M | -¥304M | -¥1,471M | -¥8,154M |
| Financing CF | -¥805M | -¥812M | ¥795M | ¥189M |
| Free CF | ¥2,094M | ¥2,737M | ¥3,831M | ¥7,592M |
| Efficiency | ||||
| ROE | 12.64% | 12.84% | 11.76% | 12.02% |
| ROA | 8.99% | 9.44% | 9.21% | 9.48% |
Latest IR Information
-
Regarding responses toward achieving management aware of capital costs and stock price (Update)
Updating the recognition of current status, capital cost, and capital efficiency. Redefining the relationship among ROE, PBR, and capital cost, and incorporating enhanced shareholder return, production at the Zaō factory, expansion of sales of new products, and strengthened dividend policy...
Read more -
Fiscal Year End June 2026 Financial Summary (Japanese GAAP) (Consolidated)
Net sales were 24,678 million yen (up 6.1% YoY), operating income was 5,476 million yen (up 2.3% YoY), and net income attributable to owners of the parent was 3,748 million yen (up 3.0% YoY). For the full-year period ending June...
Read more -
[KOA SHoji HOLDINGS CO., LTD.] Financial Summary 2026-08-07
Full-year results for the fiscal year ending June 2026 and earnings guidance for the fiscal year ending June 2027 were disclosed. Revenue is expected to continue growth, with profit improvement driven by contributions from the active pharmaceutical ingredient segment and...
Read more -
Notice of Executive Personnel Changes at the Company and Its Subsidiaries
Read more -
Notice Regarding Receipt of Dividends from Consolidated Subsidiaries
Read more
Latest News (5 items)
Company Information
About
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. It operates through Active Pharmaceutical Ingredient Sales Business and Pharmaceutical Manufacturing and Sales Business segments. The company is involved in the manufacture and sale of over-the-counter drugs and pharmacologically active injection. It also engages in contract manufacturing of pharmaceuticals; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
